4-n-butylresorcinol has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, EM; Kim, HJ; Kim, IG; Lee, JH; Lee, KB; Lee, SJ; Park, SC; Son, YH | 1 |
1 other study(ies) available for 4-n-butylresorcinol and B16 Melanoma
Article | Year |
---|---|
4-n-butylresorcinol enhances proteolytic degradation of tyrosinase in B16F10 melanoma cells.
Topics: Animals; Cell Line, Tumor; Glycosylation; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Proteolysis; Resorcinols | 2017 |